What is cagrilintide (glucagon like peptide 1 receptor agonist) used for in the management of type 2 diabetes and obesity? Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta Analysis Journal of Clinical Question